Smarter solutions for better colon cancer screening

About American BioOptics

American BioOptics (ABO) is a medical device company located in Chicago, Illinois. The company was founded in 2006 by a group of entrepreneurs, expert physicians in gastroenterology, and an internationally-renowned biomedical engineer with expertise in optical technologies.

ABO holds an exclusive license from Northwestern University and Evanston Northwestern Healthcare to multiple pending patents. The scientists, physicians, and engineers at ABO have a unique expertise in cancer cell biology, genetics, oncology, gastroenterology and optical technologies, including Four-dimensional Elastic Light-Scattering Fingerprinting (ELF), Low Coherence Enhanced Backscatter (LEBS), and Partial Wave Spectroscopy (PWS).

To date, American BioOptics’ technology has received multiple grants in excess of $16M from the nation’s leading scientific bodies, including the National Cancer Institute, the National Science Foundation, the Coulter Foundation, and the Steinkoler Foundation. These grants have financed the development of advanced prototypes and supported clinical trials of over 1000 patients. Results of these trials have been published in twenty-two scientific papers in respected medical and technical journals, with more results forthcoming. The technology has also received extensive media interest including televised news stories on ABC, CBS, NBC, and WGN television as well as the Chicago Tribune.